Zhejiang Ausun Pharmaceutical Co., Ltd. logo

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229)

Market Open
10 Aug, 06:57
SSE SSE
¥
8. 17
+0.09
+1.1139%
¥
7.23B Market Cap
- P/E Ratio
0.52% Div Yield
10.57M Volume
- Eps
¥ 8.08
Previous Close
Add Transaction
Day Range
8.05 8.28
Year Range
7.15 12.51
Want to track 603229 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

603229 trading today higher at ¥8.17, an increase of 1.1139% from yesterday's close, completing a monthly increase of 6.1039% or ¥0.47. Over the past 12 months, 603229 stock lost -18.8679%.
603229 pays dividends to its shareholders, with the most recent payment made on Jul 17, 2026. The next estimated payment will be in In 11 months on Jul 17, 2027 for a total of ¥0.064.
The last earnings report, released on May 20, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Zhejiang Ausun Pharmaceutical Co., Ltd. has completed 5 stock splits, with the recent split occurring on Jul 12, 2024.
The company's stock is traded on one exchange.

603229 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.52
-0.3141%
Shinva Medical Instrument Co., Ltd.
¥ 12.96
+0.9346%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 20.18
+1.1529%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.33
-1.6746%

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229) FAQ

What is the stock price today?

The current price is ¥8.17.

On which exchange is it traded?

Zhejiang Ausun Pharmaceutical Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 603229.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.52%.

What is its market cap?

As of today, the market cap is 7.23B.

Has Zhejiang Ausun Pharmaceutical Co., Ltd. ever had a stock split?

Zhejiang Ausun Pharmaceutical Co., Ltd. had 5 splits and the recent split was on Jul 12, 2024.

Zhejiang Ausun Pharmaceutical Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Zhiguo Zheng CEO
SSE Exchange
CNE100002XK2 ISIN
CN Country
1,174 Employees
17 Jul 2026 Last Dividend
12 Jul 2024 Last Split
- IPO Date

Overview

Zhejiang Ausun Pharmaceutical Co., Ltd. is a prominent entity in the pharmaceutical field, specializing in a wide range of activities that underscore its versatility and capability within the industry. Since its foundation in 2010, the company has set its sights on advancing the pharmaceutical sector through rigorous research and development, process development, as well as the manufacturing and sales of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. Operating from its base in Linhai, China, Zhejiang Ausun Pharmaceutical has established itself as a crucial player, contributing significantly to the development and availability of essential pharmaceutical products and services across the globe.

Products and Services

Zhejiang Ausun Pharmaceutical Co., Ltd. offers a diversified portfolio of products and services tailored to meet the needs of the pharmaceutical, cosmetics, and nutritional industries. Its products and services are designed to cater to a broad spectrum of health conditions, demonstrating the company's commitment to health and well-being through innovation and quality. Below is a delineation of its primary offerings:

  • Fluorine Products: The company specializes in the production of fluorine-containing pharmaceutical compounds, which are critical components for many drugs due to their effectiveness in enhancing bioavailability and stability.
  • Prostaglandins: These are offered as part of their product lineup, playing a crucial role in pharmaceuticals due to their diverse effects across various physiological activities, including inflammation management and blood circulation improvements.
  • Antimicrobials: Zhejiang Ausun provides antimicrobial agents used to combat infections by inhibiting the growth of or destroying microorganisms, crucial in treating and managing infectious diseases.
  • Oncology Products: The company also focuses on oncology, offering products that are pivotal in the treatment and management of cancer, showcasing its commitment to addressing one of the most challenging health issues of our time.
  • Liver Disease, Respiratory System, and Cardiac and Cerebral Vessels: It delves into the creation of specialized products aimed at treating and managing conditions related to liver diseases, respiratory system disorders, and issues pertaining to cardiac and cerebral vessels.
  • CNS (Central Nervous System) Indications: Zhejiang Ausun also develops products for treating central nervous system conditions, endorsing its commitment to addressing neurodegenerative diseases and other CNS-related disorders.
  • Development and Manufacturing Services: Beyond its product offerings, the company extends its expertise to provide comprehensive development and manufacturing services. These services cater to the pharmaceutical, cosmetics, and nutritional industries, demonstrating its holistic approach to healthcare and well-being.

Contact Information

Address: No. 5 Donghai Fourth Lane, Linhai, China, 317016
Phone: 86 576 8558 9335